{
    "title": "107_hr2801",
    "content": "The Act titled \"Prescription Drug Affordability Act\" introduces an income tax credit for prescription drugs purchased by individuals who have reached retirement age. This amendment to the Internal Revenue Code of 1986 aims to provide financial relief for seniors in purchasing necessary medications. The \"Prescription Drug Affordability Act\" introduces an income tax credit for individuals at social security retirement age. The credit covers 80% of out-of-pocket costs for prescribed drugs not covered by insurance. The term \"social security retirement age\" refers to the retirement age defined in the Social Security Act. The credit reduces the amount eligible for the medical expense deduction. The income tax credit introduced by the \"Prescription Drug Affordability Act\" covers 80% of out-of-pocket costs for prescribed drugs not covered by insurance. The credit does not apply to amounts paid from medical savings accounts and taxpayers can elect not to have the credit apply for a taxable year. Title II of the \"Prescription Drug Affordability Act\" includes amendments to the Federal Food, Drug, and Cosmetic Act. Section 201 focuses on facilitating the importation of drugs approved by the Food and Drug Administration. The effective date for these amendments is for taxable years beginning more than 1 year after the enactment of the Act. Amendments to the Federal Food, Drug, and Cosmetic Act allow for the importation of certain drugs by individuals meeting legal requirements, without the need to be the manufacturer of the drug. The imported drugs must be subject to specific regulations or contain insulin. The Secretary shall approve an application for drug importation if it meets all requirements, including approval under section 505 or 351 of the Public Health Service Act, and is not adulterated or misbranded. The Secretary must approve or refuse an application within 60 days and this does not affect any patent rights. The paragraph states that it should not affect any patent rights. SEC. 202. INTERNET SALES OF PRESCRIPTION DRUGS. Section 503(b) of the Federal Food, Drug, and Cosmetic Act is amended to allow interstate sale of prescription drugs through an Internet site if the sale complies with federal and state laws, and accurate compliance information is posted on the site. The amendment to Section 503(b) of the Federal Food, Drug, and Cosmetic Act allows for the interstate sale of prescription drugs through an Internet site, as long as the sale follows federal and state laws and accurate compliance information is provided on the site. The term 'prescription drug' refers to a drug subject to paragraph (1) of the Act. Before the one-year period ends, the Secretary of Health and Human Services must create regulations for the amendments to the Federal Food, Drug, and Cosmetic Act in sections 201 and 202. These amendments will take effect regardless of the regulations being in place."
}